NSAID gastroenteropathy: Current therapy and diagnosis

Drugs of Today

Volumn 33, Issue 2, 1997, Pages 115-122

  Wallace, John L ^a   Chin, Beth C ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; COST BENEFIT ANALYSIS; ENDOSCOPY; GASTROINTESTINAL TOXICITY; HUMAN; ULCER;

EID: 0030982307     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gamer, A. Adaptation in the pharmaceutical industry, with particular reference to gastrointestinal drugs and diseases. Scand J Gastroenterol 1992, 27 (Suppl. 193): 83-9.
2. Anonymous. Anti-arthritic medication usage: 1991. Stat Bull Metropolitan Insur Co 1992, 73: 24-5.
3. Wallace, J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997, 112: 1000-16.
4. Hoftiezer, J.W., Silvoso, G.R., Burks, M., Ivey, K.J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980, 2: 609-12.
5. Lanza, F.L., Nelson, R.S., Rack, N.W. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin and placebo on the gastric mucosal of healthy volunteers. J Clin Pharmacol 1984, 24: 89-95.
6. Kelly, J.P., Kaufinan, D.W., Jurgelon, J.M., Sheehan, J., Koff, R.S., Shapiro, S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996, 348: 1413-6.
7. Graham, D.Y., Smith, J.L., Holmes, G.I., Davies, R.O. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Clin Pharmacol Ther 1985, 38: 65-70.
8. Carson, J.L., Strom, B.L., Morse, L. et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987, 147: 1054-9.
9. Estes, L.L., Fuhs, D.W., Heaton, A.M., Butwinick, C.S. Gastric ulcer perforation, associated with the use of injectable ketorolac. Ann Pharmacother 1993, 27: 42-3.
10. Henry, D., Dobson, A., Turner, C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993, 10: 1078-88.
11. Jaszewski, R. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or non-steroidal anti-inflammatory drug therapy. J Clin Gastroenterol 1990, 12: 10-3.
12. Pounder, R. Silent peptic ulceration: Deadly silence or golden silence. Gastroenterology 1989, 96: 626-31.
13. Bloom, B.S. Direct medical costs of disease and gastrointestinal side effects during treatment of arthritis. Am J Med 1988, 83 (Suppl. 2A): 20-4.
14. Edelson, J.T., Tosteson, A.N.A., Sax, P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA 1990, 264: 41-7.
15. Stucki, G., Johannesson, M., Liang, M.H. Is misoprostol cost-effective in the prevention of non-steroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluations. Arch Intern Med 1994, 154: 2020-5.
16. Langman, M.J.S., Well, J., Wainwright, P. et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994, 343: 1075-8.
17. Lanza, F.L. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993, 88: 1318-23.
18. Paulus, H.E. FDA arthritis advisory committee meeting: Serious gastrointestinal toxicity of non-steroidal antiinflammatory drugs, etc. Arthritis Rheum 1988, 31: 1450-1.
19. Graham, D.Y., Agrawal, N.M., Roth, S.H. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet 1988, 2: 1277-80.
20. Graham, D.Y. Famotidine to prevent peptic ulcer caused by NSAIDs. New Engl J Med 1996, 335: 1322 (letter).
21. Singh, G., Fries, J.F. Famotidine to prevent peptic ulcer caused by NSAIDs. New Engl J Med 1996, 335: 1322 (letter).
22. Silverstein, F.E., Graham, D.Y., Senior, R.J. et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995, 123: 241-9.
23. Meddings, J.B., Sutherland, L.R., Byles, N.I., Wallace, J.L. Sucrose: A novel permeability marker for gastroduodenal disease. Gastroenterology 1993, 104: 1619-26.
24. Sutherland, L.R., Verhoef, M., Wallace, J.L., Van Rosendaal, G., Crutcher, R., Meddings, J.B. A simple, non-invasive marker of gastric damage: Sucrose permeability. Lancet 1994, 343: 998-1000.
25. Laufer, I. Assessment of the accuracy of double contrast gastroduodenal radiology. Gastroenterology 1976, 71: 874-8.
26. DeMeo, M. Sucrose permeability as a marker for nonsteroidal anti-inflammatory gastroduodenal injury: How sweet it is. Nutr Rev 1995, 53: 13-6.
27. Steinhart, A.M., Detsky, A.S., Bombardier, C. Economic analysis of the sucrose test: A non-invasive test of gastroduodenal mucosal damage. Gastroenterology 1996, 110: A41.
28. Rabassa, A., Goodgame, R., Sutton, F.M., Ou, C.N., Rognerud, C., Graham, D.Y. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996, 39: 159-63.
29. Puspok, A., Oberhuber, G., Wyatt, J. et al. Microscopic inflammation in the upper GI-tract and its relation to gastroduodenal permeability in Crohn's disease (CD). Gastroenterology 1996, 110: A995.
30. Cox, M.A., Iqbal, T.H., Lewis, K.O., Cooper, B.T. Serum sucrose: A new screening test for celiac disease. Gastroenterology 1996, 110: A320.
31. Kiziltas, S., Imeryuz, N., Gurcan, T. et al. Corticosteroid therapy alters gastroduodenal permeability. Gastroenterology 1996, 110: A152.
32. Lancaster-Smith, M.J., Jaderberg, M.E., Jackson, D.A. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991, 32: 252-5.
33. Roth, S., Agrawal, N., Mahowald, M. et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989, 149: 775-9.
34. Yeomans, N.D., Swannell, A.J., Eriksson, S. et al. Healing of NSAID-associated gastroduodenal ulcers and erosions: Superiority of omeprazole over ranitidine. Gastroenterology 1996, 110: A131.
35. Lain, S.K., Hui, W.M., Lau, W.Y. et al. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 1987, 92: 1193-201.
36. Cullen, D.J.E., Hawkey, G.M., Humphries, H. et al. Role of non-steroidal anti-inflammatory drugs and Helicobacter pylori in bleeding peptic ulcer. Gastroenterology 1994, 106: A66.
37. Veldhuyzen Van Zanten, S.J.O. H. pylori and NSAIDs: A meta-analysis on interactions of acute gastroduodenal injury, gastric and duodenal ulcers and upper gastrointestinal symptoms. In: Helicobacter pylori: Basic Mechanisms to Clinical Cure. Hunt, R.H., Tytgat, G. (Eds.). Kluwer Academic Publishers: Lancaster 1994, 449-60.
38. Jaszewski, R., Calzada, R., Dhar, R. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal antiinflammatory agents in patients treated with a combination of cimetidine, antacids, and enteric-coated aspirin. Dig Dis Sci 1989, 34: 1361-4.
39. Hawkey, C.J. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment. Scand J Gastroenterol 1996, 31 (Suppl. 220): 124-7.
40. Agrawal, N.M., Roth, S., Graham, D.Y. et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug induced gastric ulcer: A randomized, controlled trial. Ann Intern Med 1991, 115: 195-200.
41. Robinson, M.G., Griffin, J.W., Bowers, J. et al. Effect of ranitidine on gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs. Dig Dis Sci 1989, 34: 424-8.
42. Ehsanullah, R.S.B., Page, M.C., Tildesly, G., Wood, J.R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine. Br Med J 1988, 297: 1017-21.
43. Rashid, F., Toffolon, E.P. Misoprostol healed a benign nonsteroidal antiinflammatory drug-induced gastric ulcer in a patient with pentagastrin-fast achlorhydria. J Clin Gastroenterol 1993, 16: 219-21.
44. Janssen, M., Dijkmans, B.A.C., Vanderbroucke, J.P., Biemond, I., Lamers, C.B.H.W. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 1994, 39: 362-5.
45. Agrawal, N.M. Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. Br J Rheumatol 1995, 34 (Suppl. 1): 5-10.
46. 2-receptor antagonists. Dig Dis 1995, 13 (Suppl. 1): 62-74.
47. Simon, T.J., Berger, M.L., Hoover, M.E., Stauf-fer, L.A., Berline, R.G. A dose-ranging study of famotidine in prevention of gastroduodenal lesions associated with nonsteroidal anti-inflammatory drugs (NSAIDs): Results of a U.S. multicenter trial. Am J Gastroenterol 1994, 89: 1644.
48. Taha, A.S., Hudson, N., Hawkey, C.J. et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. New Engl J Med 1996, 334: 1435-9.
49. Hawkey, C.J., Swannell, A.J., Eriksson, S. et al. Lower frequency of gastroduodenal ulcers and erosions and dyspeptic symptoms in NSAID users during maintenance with omeprazole compared to ranitidine. Gastroenterology 1996, 110: A131.
50. Levine, J.S. Misoprostol and nonsteroidal anti-inflammatory drugs: A tale of effects, outcomes and costs. Ann Intern Med 1995, 123: 309-10.
51. Lichtenberger, L.M., Ulloa, C., Romero, J.J., Vanous, A.L., Illich, P.A., Dial, E.J. Nonsteroidal anti-inflammatory drug and phospholipid pro-drugs: Combination therapy with antisecretory agents in rats. Gastroenterology 1996, 111: 990-5.
52. Guarner, F. Prescribing nonsteroidal anti-inflammatory drugs together with antisecretory agents is safe but may be useless. Gastroenterology 1996, 111: 1145-7.
53. Graham, D.Y., White, R.R., Moreland, J.W. et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993, 119: 257-62.
54. Raskin, J.B., White, R.H., Jaszewski, R., Korsten, M.A., Schubert, T.T., Fort, J.G. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study. Am J Med 1996, 91: 223-7.